901
Views
8
CrossRef citations to date
0
Altmetric
Case Report

IgA Variant of Anti-glomerular Basement Membrane Glomerulonephritis Associated with Pulmonary Hemorrhage and Microangiopathic Hemolytic Anemia

, &
Pages 657-660 | Received 29 Nov 2011, Accepted 05 Feb 2012, Published online: 08 Mar 2012

REFERENCES

  • Borza DB, Neilson EG, Hudson BG. Pathogenesis of Goodpasture syndrome: A molecular perspective. Semin Nephrol. 2003;23:522–531.
  • Border WA, Baehler RW, Bhathena D, Glassock RJ. IgA antibasement membrane nephritis with pulmonary hemorrhage. Ann Intern Med. 1979;91:21–25.
  • Espinosa-Meléndez E, Forbes RD, Hollomby DJ, Ahuja J, Katz MG. Goodpasture’s syndrome treated with plasmapheresis. Report of a case. Arch Intern Med. 1980;140:542–543.
  • Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM. Antiglomerular basement membrane antibody mediated disease in the British Isles 1980–4. Br Med J. 1986;292:301–304.
  • Fivush B, Melvin T, Solez K, McLean RH. Idiopathic linear glomerular IgA deposition. Arch Pathol Lab Med. 1986;110:1189–1191.
  • Savige JA, Yeung SP, Bierre AR, Kincaid-Smith P. Lambda-light-chain-mediated anti-GBM disease. Nephron. 1989;52: 144–148.
  • de Caestecker MP, Hall CL, MacIver AG. Atypical antiglomerular basement membrane disease associated with thin membrane nephropathy. Nephrol Dial Transplant. 1990;15:909–913.
  • Gris P, Pirson Y, Hamels J, Vaerman JP, Quoidbach A, Demol H. Antiglomerular basement membrane nephritis induced by IgA1 antibodies. Nephron. 1991;58:418–424.
  • Fervenza FC, Terreros D, Boutaud A, . Recurrent Goodpasture’s disease due to a monoclonal IgA-kappa circulating antibody. Am J Kidney Dis. 1999;34:549–555.
  • Shaer AJ, Stewart LR, Cheek DE, Hurray D, Self SE. IgA antiglomerular basement membrane nephritis associated with Crohn’s disease: A case report and review of glomerulonephritis in inflammatory bowel disease. Am J Kidney Dis. 2003;41: 1097–1109.
  • Ghohestani RF, Rotunda SL, Hudson B, . Crescentic glomerulonephritis and subepidermal blisters with autoantibodies to alpha5 and alpha6 chains of type IV collagen. Lab Invest. 2003;83:605–611.
  • Ho J, Gibson IW, Zacharias J, Fervenza F, Colon S, Borza DB. Antigenic heterogeneity of IgA anti-GBM disease: New renal targets of IgA autoantibodies. Am J Kidney Dis. 2008;52: 761–765.
  • Borza DB, Chedid MF, Colon S, Lager DJ, Leung N, Fervenza FC. Recurrent Goodpasture’s disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen. Am J Kidney Dis. 2005;45:397–406.
  • Stave GM, Croker BP. Thrombotic microangiopathy in anti-glomerular basement membrane glomerulonephritis. Arch Pathol Lab Med. 1984;108:747–751.
  • Stallworthy E, Yehia M. Thrombotic microangiopathy in a patient with anti-glomerular basement membrane antibody disease. Nephrology (Carlton). 2006;11:375–376.
  • Terryn W, Benoit D, Van Loo A, . Goodpasture’s syndrome associated with autoimmune thrombotic thrombocytopenic purpura an unusual case. Nephrol Dial Transplant. 2007;22: 3672–3673.
  • Torok N, Niazi M, Al Ahwel Y, Taleb M, Taji J, Assaly R. Thrombotic thrombocytopenic purpura associated with anti-glomerular basement membrane disease. Nephrol Dial Transplant. 2010;25:3446–3449.
  • Watanabe H, Kitagawa W, Suzuki K, . Thrombotic thrombocytopenic purpura in a patient with rapidly progressive glomerulonephritis with both anti-glomerular basement membrane antibodies and myeloperoxidase anti-neutrophil cytoplasmic antibodies. Clin Exp Nephrol. 2010;14:598–601.
  • Shin JI, Park SJ, Kim JH. Is there a link between thrombotic thrombocytopenic purpura and anti-glomerular basement membrane disease? Nephrol Dial Transplant. 2011;26:2058–2059.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.